相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of High-Field Magnetic Resonance Imaging in Parkinsonian Disorders: Pushing the Boundaries Forward
Stephane Lehericy et al.
MOVEMENT DISORDERS (2017)
Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease
S. Reimao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
The role of biomarkers and imaging in Parkinson's disease
Musleh A. Algarni et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Accuracy of clinical diagnosis of Parkinson disease A systematic review and meta-analysis
Giovanni Rizzo et al.
NEUROLOGY (2016)
CHARACTERIZATION OF GRAY MATTER ATROPHY FOLLOWING 6-HYDROXYDOPAMINE LESION OF THE NIGROSTRIATAL SYSTEM
Robert Westphal et al.
NEUROSCIENCE (2016)
Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression
N. W. Sterling et al.
JOURNAL OF PARKINSONS DISEASE (2016)
The role of biomarkers and imaging in Parkinson's disease
Musleh A. Algarni et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors
Ian F. Harrison et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?
Darryl Bannon et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of Parkinson's disease - phagocyte influx to the brain is promoted by bilberry-enriched diet
Ana Virel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
VOXEL-BASED MORPHOMETRY OF THE MARMOSET BRAIN: IN VIVO DETECTION OF VOLUME LOSS IN THE SUBSTANTIA NIGRA OF THE MPTP-TREATED PARKINSON'S DISEASE MODEL
K. Hikishima et al.
NEUROSCIENCE (2015)
Brain-mapping projects using the common marmoset
Hideyuki Okano et al.
NEUROSCIENCE RESEARCH (2015)
Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease
Elijah Mak et al.
PARKINSONISM & RELATED DISORDERS (2015)
Parkinson Disease: Diffusion MR Imaging to Detect Nigrostriatal Pathway Loss in a Marmoset Model Treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Keigo Hikishima et al.
RADIOLOGY (2015)
Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury
Ayse Ulusoy et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease
Ilse S. Pienaar et al.
BRAIN STRUCTURE & FUNCTION (2015)
Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis
E. Mak et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Magnetic Resonance Imaging (MRI) to Study Striatal Iron Accumulation in a Rat Model of Parkinson's Disease
Ana Virel et al.
PLOS ONE (2014)
Diffusion Tensor Imaging of Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study
Amanda Worker et al.
PLOS ONE (2014)
Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy
Amanda Worker et al.
PLOS ONE (2014)
Alpha-synuclein biology in Lewy body diseases
Woojin Scott Kim et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies
Clare J. Finlay et al.
FRONTIERS IN NEUROLOGY (2014)
Lithium, Gray Matter, and Magnetic Resonance Imaging Signal
David A. Cousins et al.
BIOLOGICAL PSYCHIATRY (2013)
A comparison of automated anatomical-behavioural mapping methods in a rodent model of stroke
William R. Crum et al.
JOURNAL OF NEUROSCIENCE METHODS (2013)
Registration of challenging pre-clinical brain images
William R. Crum et al.
JOURNAL OF NEUROSCIENCE METHODS (2013)
Biomarkers in Parkinson's disease (recent update)
Sushil Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study
Stefano Delli Pizzi et al.
PLOS ONE (2013)
Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease
Javier Pagonabarraga et al.
PLOS ONE (2013)
Is R2* a New MRI Biomarker for the Progression of Parkinson's Disease? A Longitudinal Follow-Up
Miguel Ulla et al.
PLOS ONE (2013)
Substantia Nigra Volume Loss Before Basal Forebrain Degeneration in Early Parkinson Disease
David A. Ziegler et al.
JAMA NEUROLOGY (2013)
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3T and systematic review with meta-analysis
Stefan T. Schwarz et al.
NEUROIMAGE-CLINICAL (2013)
Classic and New Animal Models of Parkinson's Disease
Javier Blesa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Do Levodopa Treatments Modify the Morphology of the Parkinsonian Brain?
Anthony C. Vernon et al.
MOVEMENT DISORDERS (2012)
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
Jennifer G. Goldman et al.
MOVEMENT DISORDERS (2012)
Modeling Parkinson's Disease in Primates: The MPTP Model
Gregory Porras et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse
Jason P. Lerch et al.
FRONTIERS IN NEUROINFORMATICS (2012)
In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model
Guadalupe Soria et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Evolution of Extra-Nigral Damage Predicts Behavioural Deficits in a Rat Proteasome Inhibitor Model of Parkinson's Disease
Anthony C. Vernon et al.
PLOS ONE (2011)
Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease
Anthony C. Vernon et al.
BMC NEUROSCIENCE (2010)
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
Patrice Peran et al.
BRAIN (2010)
Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
Anthony C. Vernon et al.
BRAIN RESEARCH REVIEWS (2010)
The MPTP marmoset model of Parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases
Ingrid H. C. H. M. Philippens et al.
DRUG DISCOVERY TODAY (2010)
An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat
Salma Bukhatwa et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Web-accessible digital brain atlas of the common marmoset (Callithrix jacchus)
Hironobu Tokuno et al.
NEUROSCIENCE RESEARCH (2009)
Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract
Nadja Van Camp et al.
NMR IN BIOMEDICINE (2009)
From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease
Peter Jenner
PARKINSONISM & RELATED DISORDERS (2009)
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease
Giovanni Rizzo et al.
BRAIN (2008)
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy
S. A. M. van Vlieta et al.
BRAIN RESEARCH (2008)
Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets
K. A. Stockwell et al.
EXPERIMENTAL NEUROLOGY (2008)
Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging
Marina Delfino et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Dopamine neuron systems in the brain:: an update
Anders Bjorklund et al.
TRENDS IN NEUROSCIENCES (2007)
Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques
Zhiming Zhang et al.
NEUROIMAGE (2006)
Pramipexole protects against MPTP toxicity in non-human primates
MM Iravani et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Marmoset monkey models of Parkinson's disease: Which model, when and why?
A Eslamboli
BRAIN RESEARCH BULLETIN (2005)
Anisotropic multi-scale fluid registration: evaluation in magnetic resonance breast imaging
WR Crum et al.
PHYSICS IN MEDICINE AND BIOLOGY (2005)
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys
KA Dorph-Petersen et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study
G Pelled et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging
T Kondoh et al.
EXPERIMENTAL NEUROLOGY (2005)
A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets
MM Iravani et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein:: A new primate model of Parkinson's disease
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Thresholding of statistical maps in functional neuroimaging using the false discovery rate
CR Genovese et al.
NEUROIMAGE (2002)
分享论文
